Similarities and differences between SNDS and other claim databases On-Demand Webinar Similarities and differences between SNDS and other claim databases Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…Certara2021 年 5 月 25 日
Using Authoring Templates to Write the Right Way On-Demand Webinar Using Authoring Templates to Write the Right Way Creating submission-ready regulatory documents that are consistent in presentation, appropriate in content, and formatted to…Certara2021 年 5 月 25 日
Overview of SNDS and the key working practices to access the database and ongoing SNDS developments On-Demand Webinar Overview of SNDS and the key working practices to access the database and ongoing SNDS developments Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…Certara2021 年 5 月 25 日
PBPK modeling approaches to assess risks associated with bioequivalence in drug development On-Demand Webinar PBPK modeling approaches to assess risks associated with bioequivalence in drug development In this webinar, Dr. Ioannis Loisios-Konstantinidis from Novartis, Switzerland discussed: Opportunities and challenges in conducting…Certara2021 年 5 月 19 日
Evidence generation in Europe- How valuable is the French National administrative health data (SNDS) On-Demand Webinar Evidence generation in Europe- How valuable is the French National administrative health data (SNDS) Watch this presentation to learn • Overview of the SNDS and the key working practices…Certara2021 年 5 月 7 日
The Wizard of Oligos: There’s no place like having a successful drug development program! 网络研讨会点播 The Wizard of Oligos: There’s no place like having a successful drug development program! Oligonucleotide therapies— nucleic acid polymers with the potential to treat or manage a wide range…Certara2021 年 4 月 30 日
The Promises and Pitfalls of Gene Therapy for Rare Diseases On-Demand Webinar 基因疗法治疗罕见病的希望与陷阱 The state of gene therapy faces much uncertainty as recent regulatory and clinical setbacks have…Certara2021 年 4 月 29 日
Part 3: Oligonucleotide therapeutic development: Clinical pharmacology considerations On-Demand Webinar 第 3 部分:Oligonucleotide therapeutic development: Clinical pharmacology considerations In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…Certara2021 年 4 月 21 日
Part 2: Oligonucleotide therapeutic development: Pre-clinical and translational considerations On-Demand Webinar 第 2 部分:Oligonucleotide therapeutic development: Pre-clinical and translational considerations In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…Certara2021 年 4 月 21 日
Part 1: What are oligonucleotide therapeutics, and how do they work? 网络研讨会点播 第 1 部分:What are oligonucleotide therapeutics, and how do they work? In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…Certara2021 年 4 月 21 日